trusted seller
Abingem 1.4 gm Injection Abingem 1.4 gm Injection
Abingem 1.4 gm Injection
Abingem 1.4 gm Injection

Abingem 1.4 gm Injection

उत्पाद विवरण:

  • उत्पत्ति India
  • संकेत Used in the treatment of various cancers including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer.
  • खुराक प्रपत्र Injection
  • नमक की संरचना Gemcitabine Hydrochloride (1.4 gm)
  • एंजाइम के प्रकार
  • फ़ीचर
  • एप्लीकेशन
  • अधिक देखने के लिए क्लिक करें
X

मूल्य और मात्रा

  • 1
  • Hypersensitivity to Gemcitabine or other components
  • Abingem
  • Single vial
  • Yes, with sterile water for injection before use
  • May include bone marrow suppression, nausea, vomiting, fever, and other chemotherapy-related effects
  • Adults only—dose determined by physician
  • No; conventional cytotoxic chemotherapy
  • 11747532
  • 1.4 gm
  • Intas Pharmaceuticals Ltd.
  • Cytotoxic—administered under medical supervision
  • Prescription only
  • Intravenous (IV) use only

उत्पाद की विशेषताएं

  • Store below 25°C, protect from light, do not freeze
  • Not relevant (no enzymatic activity)
  • Approximately 7.0
  • Injection
  • Gemcitabine Hydrochloride (1.4 gm)
  • Used in the treatment of various cancers including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer.
  • India
  • महीने
  • Hypersensitivity to Gemcitabine or other components
  • Abingem
  • Single vial
  • Yes, with sterile water for injection before use
  • May include bone marrow suppression, nausea, vomiting, fever, and other chemotherapy-related effects
  • Adults only—dose determined by physician
  • No; conventional cytotoxic chemotherapy
  • 11747532
  • 1.4 gm
  • Intas Pharmaceuticals Ltd.
  • Cytotoxic—administered under medical supervision
  • Prescription only
  • Intravenous (IV) use only

व्यापार सूचना

  • प्रति महीने
  • दिन

उत्पाद वर्णन

Product introduction

Abingem 1.4gm Injection is used in the treatment of non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer.

Abingem 1.4gm Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include nausea, vomiting, loss of appetite, hair loss and low blood platelets. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.



Precise Chemotherapy Administration

Abingem Injection delivers high-purity Gemcitabine Hydrochloride for effective cancer therapy. Its sterile, single-use formulation ensures safe, accurate dosing. This cytotoxic drug targets a range of cancers and is designed for intravenous infusion after reconstitution, providing a reliable choice for oncologists in clinical settings.


Strict Safety and Storage Requirements

Abingem must be stored below 25C, away from light and never frozen, to preserve its efficacy. As a cytotoxic agent, it should be handled and administered only by trained medical personnel, adhering to all safety protocols to minimize risk to patients and healthcare staff.

FAQ's of Abingem 1.4 gm Injection:


Q: How should Abingem 1.4 gm Injection be prepared and administered?

A: Abingem 1.4 gm Injection must be reconstituted with sterile water for injection by a qualified healthcare professional and administered intravenously. It should only be used in a medical facility under close supervision.

Q: What types of cancer can Abingem Injection treat?

A: Abingem is indicated for the treatment of several cancers, including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer, as prescribed by a physician.

Q: Who is suitable for treatment with Abingem Injection?

A: This injection is designed for adult patients only. The dosage and duration are determined by a physician based on the patient's type and stage of cancer as well as overall health status.

Q: What are the common side effects of Abingem Injection?

A: Potential side effects include bone marrow suppression, nausea, vomiting, fever, and other symptoms commonly associated with chemotherapy. Patients should report any unusual or severe reactions to their physician immediately.

Q: Are there any storage recommendations for Abingem Injection?

A: Abingem should be stored below 25C, protected from light, and should not be frozen in order to maintain stability and effectiveness for up to 24 months from the date of manufacture.

Q: Can Abingem Injection be used in patients with known hypersensitivity to Gemcitabine?

A: No, Abingem is contraindicated in individuals with known hypersensitivity to Gemcitabine or other components of the formulation.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
मोबाइल number

Email

एंटी कैंसर इंजेक्शन अन्य उत्पाद



Back to top